BRIEF-IntelGenx and Redhill Biopharma to commercialize migraine drug with Pharmatronic in South Korea

* IntelGenx and Redhill Biopharma announce definitive agreement for commercialization of Rizaport(r) for migraines with Pharmatronic Co in South Korea Source text for Eikon: Further company coverage: